Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | HBB | P68871 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | CNR2 | P34972 | 14/20 | 0.60 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | RORA | P35398 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9397292 | 0.98 | KDM4E (0.68) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL5012113 | 0.98 | KDM4E (0.68) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL8124194 | 0.98 | KDM4E (0.68) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL10945941 | 0.95 | ALDH1A1 (0.71) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL31739343 | 0.95 | ALDH1A1 (0.71) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL11340644 | 0.94 | KDM4E (0.76) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL30884614 | 0.91 | KDM4E (0.54) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL29208327 | 0.91 | KDM4E (0.54) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL11757062 | 0.89 | KDM4E (0.76) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19974241 | 0.87 | ALDH1A1 (0.57) | KDM4EMEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180309080-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-10-25 | — | — | US | claimed |
| US-20140034932-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-02-06 | — | — | US | claimed |
| CN-108321303-B | Light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2021-03-09 | — | — | CN | disclosed |
| CN-108539032-B | Light-emitting element, light-emitting device, electronic device, and lighting device | 株式会社半导体能源研究所 | 2020-02-21 | — | — | CN | disclosed |
| US-20180309080-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-10-25 | — | — | US | disclosed |
| US-20140034932-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-02-06 | — | — | US | disclosed |
| US-8207214-B2 | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-06-26 | — | — | US | disclosed |
| US-20110046197-A1 | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THE PREPARATION THEREOF | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCE (IT) | 2011-02-24 | — | — | US | disclosed |
| US-7879900-B2 | Antiinflammatory agents; antitumor agents; Alzheimer's disease;atherosclerosis | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2011-02-01 | — | — | US | disclosed |
| EP-1910288-B1 | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THE PREPARATION THEREOF | ACRAF (IT) | 2010-06-23 | — | — | EP | disclosed |
| US-20080207727-A1 | 3-Aminocarbazole Compounds, Pharmaceutical Composition Containing the Same and Method for the Preparation Thereof | AZIENDE CHIMICHE RIUNTE ANGELINI FRANCE (IT) | 2008-08-28 | — | — | US | disclosed |
| EP-1910288-A1 | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THE PREPARATION THEREOF | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007014687-A1 | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THE PREPARATION THEREOF | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2007-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207727-A1 | 3-Aminocarbazole Compounds, Pharmaceutical Composition Containing the Same and Method for the Preparation Thereof | CYP2C19, CYP2C9, CYP3A43 | KDM4E 1007/4885MEN1 1522/4885ALDH1A1 1131/4885 |
| US-20110046197-A1 | 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THE PREPARATION THEREOF | IL17A, APC, IL33 | KDM4E 3434/4885MEN1 2803/4885ALDH1A1 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.